JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maxwell, R. A.
Right arrow Articles by Povalski, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maxwell, R. A.
Right arrow Articles by Povalski, H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 124, Issue 2, 127-134, 1958
Copyright © 1958 by American Society for Pharmacology and Experimental Therapeutics


CONCERNING THE MECHANISMS OF THE CARDIOVASCULAR ACTIONS OF HEXAHYDRO-1-AZEPINEPROPIONAMIDOXIME (SU-4029)

R. A. Maxwell 1, A. J. Plummer 1, A. I. Daniel 1, F. Schneider 1, and H. Povalski 1

1 Research Department, CIBA Pharmaceutical Products Inc., Summit, New Jersey

The blockade of norepinephrine produced by the "reversible" adrenergic blocking agent phentolamine is negated by Su-4029. The blockade of norepinephrine produced by the "irreversible" blocking agent Dibenamine is not negated by Su-4029. Since phentolamine and Dibenamine are generally considered to function at the same locus in the adrenergic receptor substance these facts indicate that Su-4029 may have an action in the substance of the alpha receptors and that it may be at the same site as that affected by Dibenamine and phentolamine. The responses to a series of pressor phenylalkylamines following Su-4029 pretreatment fall into 3 categories: 1) irreversibly blocked are the amines with no or only p-hydroxylation; 2) reversibly blocked are the amines with hydroxylation on the carbon adjacent to the ring, i.e., the beta carbon; and 3) not blocked or augmented are the amines with m and p-hydroxylation or m or p plus beta-hydroxylation. It is suggested that part of the action, at least, of Su-4029 is to "deform" that portion of the alpha receptor substance which is affected by adrenergic blocking agents such as phentolamine and Dibenamine.

Submitted on June 25, 1958







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1958 by the American Society for Pharmacology and Experimental Therapeutics.